Treasury Stock Method

The treasury stock method (TSM) is an earnings-per-share calculation that estimates the incremental common shares created by assumed exercise of certain options, warrants, and similar instruments. It assumes the instruments are exercised at the beginning of the reporting period, or when issued if later, and that the assumed proceeds are used to repurchase shares at the average market price during the period. Only the net incremental shares enter diluted EPS when their effect is dilutive.

No exercise or repurchase has to occur. The method is an accounting convention for the diluted-EPS denominator, not a record of actual treasury-stock transactions, a forecast of holder behavior, or a complete measure of potential ownership dilution.

Key Takeaways

• The treasury stock method adds incremental shares, not every share underlying an option or warrant.
• It uses an average market price for the reporting period, not simply the closing or current share price.
• The assumed repurchase is hypothetical. It does not mean the issuer bought shares or holds additional treasury stock.
• Options and warrants generally contribute incremental shares only when the prescribed calculation is dilutive.
• Instruments outstanding for only part of the period must be time-weighted under the applicable rules.
• Assumed proceeds can include more than cash exercise payments for some share-based awards.
• Convertible debt and convertible preferred shares generally require an if-converted analysis rather than the simple treasury stock method.
• Reported diluted EPS can exclude a large number of potential shares that are antidilutive for the period.

Why the Method Is Used

Simply adding all option and warrant shares would ignore the value the issuer would receive upon assumed exercise. The treasury stock method recognizes that exercise proceeds could theoretically offset part of the new share count through a repurchase at the period’s average market price.

The resulting net number is intended for earnings per share reporting. It answers a narrow question:

How many incremental common shares would these instruments add to the diluted-EPS denominator under the prescribed assumptions for this reporting period?

It does not answer whether holders will exercise, whether the company will repurchase shares, how much economic dilution will occur, or what the shares are worth.

Treasury Stock Method Formula

Let:

• Q = weighted-average common shares assumed issued on exercise;
• P = assumed proceeds under the applicable accounting requirements; and
• M = average market price per common share during the relevant period.

The assumed repurchase is:

The simplified incremental-share amount is:

For a simple one-for-one option or warrant with weighted-average quantity N and exercise price K, assumed proceeds are N x K. The formula becomes:

This simplified form applies only when the instrument is otherwise eligible, M exceeds K, and exercise cash is the complete assumed-proceeds amount. Awards with compensation cost, variable terms, contingencies, non-one-for-one ratios, or alternative settlement can require a different input or method.

Worked Example

Assume a company reports:

• 1,000,000 weighted-average common shares outstanding;
• 100,000 options outstanding for the full year;
• a $50 exercise price per share;
• a $70 average market price during the year; and
• $10,000,000 of earnings available to common shareholders.

Assume the options are eligible for the treasury stock method, all other complexities are ignored, and there is no numerator adjustment.

Step 1: Calculate Assumed Exercise Proceeds

Step 2: Calculate Shares Assumed Repurchased

Step 3: Calculate Incremental Shares

Step 4: Calculate Basic and Diluted EPS

The method adds 28,571 shares, not the full 100,000 underlying shares. The difference represents shares hypothetically repurchased with the assumed exercise proceeds.

Why Average Market Price Matters

A current market price is not the same measurement as the required period average. EPS covers a reporting period, so the treasury stock method uses a meaningful average market price for that period under the relevant accounting guidance.

Using the example’s 100,000 options and $50 exercise price:

If the period average was $70, substituting the $90 closing price would overstate incremental shares in this illustration. The closing price may be useful for a period-end valuation or a forward scenario, but it is not automatically the correct input for reported diluted EPS.

The selected average should also be internally consistent with the reporting period and share class. A daily average can be precise; other averaging methods may be acceptable if they produce a meaningful result under the applicable guidance. An analyst should normally start with the issuer’s disclosed diluted-share reconciliation rather than reconstructing an undocumented average from a chart.

Timing and Weighting

The method assumes exercise at the start of the period, or at the issuance date if the instrument was issued later. Instruments outstanding for only part of the period therefore should not be treated as if they existed for the entire year.

Suppose 100,000 identical options are granted halfway through a simplified 12-month year. Before considering other requirements, their weighted-average quantity is approximately:

At a $50 exercise price and $70 average market price, the simplified incremental amount is:

Actual calculations can use days rather than months and may apply interim or year-to-date conventions. Grants, exercises, forfeitures, expirations, modifications, and corporate actions can divide the population into several tranches with different quantities and prices.

What Counts as Assumed Proceeds?

For a plain cash-exercise warrant, assumed proceeds may begin with the contractual exercise payment. For employee and nonemployee share-based awards, the accounting calculation can include other prescribed amounts.

Under U.S. GAAP, Topic 260 and Topic 718 contain detailed rules for the assumed proceeds and treatment of share-based payment awards. Changes to tax accounting have also altered parts of historical calculations. Do not reuse an old worksheet without confirming that its components match the current reporting framework and award terms.

Under IFRS, IAS 33 applies an economically similar net-share concept to options, warrants, and equivalents, although the detailed language and treatment should be read in that framework. A company should not mix U.S. GAAP and IFRS inputs in one reported calculation.

When Instruments Are Antidilutive

Diluted EPS includes potential common shares only when their assumed inclusion is dilutive under the applicable test. A potential share is antidilutive when including it would increase EPS or reduce loss per share rather than reduce EPS or increase loss per share.

For a simple fixed-price call option or warrant, no incremental shares arise from the formula when the exercise price equals the average market price:

When K exceeds M, the simple formula produces a negative amount. Negative incremental shares are not added as dilution; the instrument is generally antidilutive in that simplified setting.

A company reporting a loss often excludes options and warrants because adding shares would reduce the loss per share. That exclusion does not make the instruments worthless and does not remove possible future dilution. If earnings or the average market price changes in a later period, the same instruments may become dilutive.

Instrument ordering and the control number used for anti-dilution testing can also matter under the applicable standard. A complete EPS calculation should apply the reporting framework rather than test each instrument in isolation using net income alone.

Treasury Stock Method vs. Other EPS Methods

Different potential common shares require different analysis:

Calling every potential-share calculation “treasury stock method” is inaccurate. In particular, adding convertible shares without the related numerator analysis can materially distort diluted EPS.

Treasury Stock Method vs. Actual Treasury Stock

Treasury stock consists of shares an issuer actually reacquired and holds. The treasury stock method is only a calculation convention.

If an option is actually exercised, the issued share enters the basic weighted-average denominator from the appropriate date. Any real repurchase is recorded separately based on the actual transaction. The accounting assumption does not net those events away in the cash-flow statement or equity rollforward.

Reported Diluted EPS vs. Fully Diluted Capitalization

The treasury stock method is not a gross fully diluted cap-table calculation.

• Reported diluted EPS is a period-based accounting measure. It uses weighted averages, prescribed methods, numerator adjustments, and anti-dilution exclusions.
• Fully diluted capitalization is usually a transaction, ownership, or valuation scenario. It may include all granted awards, unused plan shares, warrants, convertibles, earnouts, or other claims under stated assumptions.
• Actual future shares depend on exercise, vesting, conversion, settlement, expiration, forfeiture, and corporate actions.

An out-of-the-money option can be excluded from current diluted EPS while remaining economically important to a long-term cap table. Conversely, an award included in diluted EPS may later be forfeited. The measures should be reconciled, not treated as interchangeable.

How Analysts Use the Method

The treasury stock method helps analysts:

• reconcile basic and diluted weighted-average shares;
• understand how options and warrants affect reported per-share earnings;
• separate gross underlying shares from net accounting dilution;
• identify the effect of average share price and exercise price;
• compare reported diluted EPS with stock-compensation and warrant disclosures; and
• build forward EPS scenarios with transparent assumptions.

For forecasting, analysts often need more than the latest reported diluted-share count. Future earnings, average share price, option grants, exercises, forfeitures, warrant terms, repurchases, acquisitions, and conversion activity can all change the denominator. A forward model should state whether it follows accounting diluted EPS or a valuation-specific share-count convention.

How to Review a Filing

1. Start with the EPS note and reconcile basic weighted-average shares to diluted weighted-average shares.
2. Identify each class of options, warrants, awards, convertibles, and contingent shares.
3. Match each instrument to its prescribed EPS method; do not apply one formula to all classes.
4. Confirm the relevant average market price and period, not merely the reporting-date quote.
5. Reconcile quantities and exercise prices to the stock-compensation, warrant, debt, and equity notes.
6. Identify instruments excluded as antidilutive and preserve them in future-dilution scenarios.
7. Review grants, exercises, forfeitures, expirations, modifications, and settlements during the period.
8. Check whether share-based award proceeds include required unrecognized compensation amounts.
9. Separate the assumed EPS repurchase from actual share-repurchase activity.
10. Recalculate only after documenting the issuer’s accounting framework, share class, instrument terms, and rounding convention.

For U.S. public companies, the SEC’s EDGAR database provides the financial statements and instrument agreements needed to support this review.

Common Mistakes and Limitations

• Using the period-end or current share price instead of the applicable average market price.
• Adding every underlying option or warrant share to diluted EPS.
• Treating assumed repurchased shares as an actual buyback or treasury-stock balance.
• Applying the method to convertible debt without considering the if-converted numerator adjustment.
• Including antidilutive instruments merely because they are legally exercisable.
• Assuming instruments excluded during a loss period can never dilute future EPS.
• Ignoring the time an instrument was outstanding during the period.
• Using exercise cash as the only assumed proceeds for every share-based award.
• Mixing gross fully diluted capitalization with the accounting diluted-EPS denominator.
• Ignoring warrant ratios, anti-dilution adjustments, variable settlement, and corporate actions.
• Comparing diluted share counts from periods with different average share prices as if instrument activity were the only change.
• Treating a lower incremental-share count as proof that the compensation plan or financing created value.

The treasury stock method is useful because it applies a consistent accounting convention. Its precision should not be confused with economic certainty. The formula does not value the instruments, predict exercise, measure total compensation cost, or determine whether issuing them was beneficial.

Authoritative Sources

• The FASB’s Accounting Standards Update 2020-06 reproduces and amends Topic 260 guidance on options, warrants, average market price, the treasury stock method, and the if-converted method.
• The FASB’s Accounting Standards Update 2018-07 includes Topic 718 and Topic 260 provisions for share-based payment awards and diluted EPS.
• The IFRS Foundation’s IAS 33 overview explains basic and diluted EPS, potential ordinary shares, options, warrants, convertibles, and denominator reconciliation.
• The FASB’s Statement No. 128 is the historical EPS standard now incorporated into the Accounting Standards Codification; its implementation guidance explains meaningful average market price and the original treasury stock method framework.

Related Terms

• Earnings Per Share: The reported per-share measure whose diluted denominator can use the treasury stock method.
• Weighted-Average Shares: The period-weighted starting denominator for basic EPS.
• Treasury Stock: Shares actually reacquired by an issuer, distinct from the method’s hypothetical repurchase.
• Warrant: A purchase right whose net incremental shares may enter diluted EPS.
• Employee Stock Option: A compensation award subject to exercise, vesting, and diluted-EPS rules.
• Share-Based Payment: The accounting category whose award terms can affect assumed proceeds.
• Equity Overhang: Potential future shares measured more broadly than reported diluted EPS.
• Share Dilution: Ownership and per-share effects of actual or potential share issuance.

FAQs

Check Your Understanding

This article is for financial education only. It is not accounting, securities, valuation, compensation, tax, legal, or investment advice. Apply the current reporting framework and complete instrument terms to an actual issuer’s calculation.